e-learning
resources
Barcelona 2010
Tuesday, 21.09.2010
COPD: cardiovascular comorbidities
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The difficulties of functional class heart failure assessment in the patients with concomitant chronic obstructive pulmonary disease
P. Fedotov, N. Shaporova, M. Sitnikova, N. Saphyanova, V. Iablonscaya, V. Dorofeykov, E. Shlyakhto (St. Petersberg, Russian Federation)
Source:
Annual Congress 2010 - COPD: cardiovascular comorbidities
Session:
COPD: cardiovascular comorbidities
Session type:
E-Communication Session
Number:
5218
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. Fedotov, N. Shaporova, M. Sitnikova, N. Saphyanova, V. Iablonscaya, V. Dorofeykov, E. Shlyakhto (St. Petersberg, Russian Federation). The difficulties of functional class heart failure assessment in the patients with concomitant chronic obstructive pulmonary disease. Eur Respir J 2010; 36: Suppl. 54, 5218
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on Basic translational and clinical research – building a career in paediatric pulmonology- experiences from clinicians in lower middle income countries
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Beta-blockade therapy in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure in the presence and absence of pulmonary hypertension
Source: Annual Congress 2010 - COPD: management
Year: 2010
Influence of concomitant chronic heart failure on incorrect evaluation of chronic obstructive pulmonary disease assessment tests
Source: International Congress 2019 – Cardiovascular comorbidities in COPD
Year: 2019
The heart rate variability in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2008 - COPD
Year: 2008
The prospective impact of chronic obstructive pulmonary disease on short-term prognosis of patients with chronic heart failure
Source: Annual Congress 2010 - COPD: cardiovascular comorbidities
Year: 2010
Short-term outcomes in community heart failure patients with chronic obstructive pulmonary disease
Source: Annual Congress 2011 - Comorbidities and management in primary care
Year: 2011
Differences of functional capacity between patients with left heart failure and rightheart failure associated with chronic pulmonary diseases
Source: Virtual Congress 2020 – Pulmonary embolism and beyond
Year: 2020
Unrecognised ventricular dysfunction in COPD
Source: Eur Respir J 2012; 39: 51-58
Year: 2012
Unrecognised ventricular dysfunction in COPD
Source: Eur Respir J 2011; 39: 51-58
Year: 2012
Association of phase angle and hypoxemia in ambulatory patients with chronic obstructive pulmonary disease and heart failure.
Source: International Congress 2018 – Interdependence of COPD and comorbidities and the underlying mechanisms
Year: 2018
Prevalence of comorbidities in patients with chronic obstructive pulmonary disease in presence of heart failure
Source: International Congress 2016 – Comorbidities and exacerbations in COPD
Year: 2016
The assessment of exercise capacity in chronic obstructive pulmonary disease patients
Source: Eur Respir J 2005; 26: Suppl. 49, 63s
Year: 2005
Impact of chronic obstructive pulmonary disease and heart failure on the phase angle in hospitalized subjects
Source: International Congress 2018 – Functional assessment of COPD
Year: 2018
A study of neuromuscular dysfunction in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2012 - Quality of life and clinical parametres in monitoring airway diseases
Year: 2012
The effect of early pulmonary rehabilitation on the treatment of ICU chronic obstructive pulmonary disease with severe respiratory failure
Source: International Congress 2018 – Muscles and diaphragm, and quality improvement
Year: 2018
Analysis of parameters of lung function in patients with severe chronic obstructive pulmonary disease
Source: Eur Respir J 2001; 18: Suppl. 33, 214s
Year: 2001
Exercise heart rate recovery in chronic obstructive pulmonary disease patients
Source: Annual Congress 2010 - Exercise in COPD
Year: 2010
Frequency of adverse consequences after spirography in patients with chronic obstructive pulmonary disease and concomitant ischemic heart disease
Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases
Year: 2016
The influence of co-morbidity on the outcome of non-invasive ventilatory support in patients with acute respiratory failure (ARF) in chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2002; 20: Suppl. 38, 277s
Year: 2002
Study of heart rate variability in patients with chronic obstructive pulmonary disease
Source: Virtual Congress 2020 – Monitoring of patients with COPD
Year: 2020
Association between endothelial dysfunction and nutrient consumption in patients with chronic obstructive pulmonary disease and heart failure.
Source: International Congress 2018 – Nutrition and metabolic syndrome in COPD
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept